Steven Cohen’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
Other funds holding AUTL
Steven Cohen's AUTL Position: Q3 2026 in Review
Steven Cohen increased its Autolus Therapeutics (AUTL) stake by 89% in Q3 2026, buying an estimated $121K and bringing the position to 134,420 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #3410.
Steven Cohen first reported a position in AUTL in Q3 2019 and has held it in 11 quarters since. The position peaked at $4.17M in Q4 2019. 91 funds tracked by Wall St. Rank hold AUTL as of Q3 2026.
- Steven Cohen held 134,420 shares of Autolus Therapeutics worth $261K as of Q3 2026.
- Steven Cohen bought 63,193 Autolus Therapeutics shares in Q3 2026, an estimated $121K.
- Autolus Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3410 holding.
- Steven Cohen first reported a position in Autolus Therapeutics in Q3 2019 and has held it in 11 quarters since.
- Steven Cohen's Autolus Therapeutics position peaked at $4.17M in Q4 2019.
- 91 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.